カテゴリー： Market Monitor Global, 世界, 医療/バイオ

ヒト用狂犬病ワクチン接種の世界市場見通し2023年-2029年

◆英語タイトル：Human Rabies Vaccination Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8778 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：78 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Human Rabies Vaccination Market 調査レポートは次の情報を含め、グローバルにおけるのヒト用狂犬病ワクチン接種市場規模と予測を収録しています。・世界のヒト用狂犬病ワクチン接種市場：売上、2018年-2023年、2024年-2029年
・世界のヒト用狂犬病ワクチン接種市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のヒト用狂犬病ワクチン接種市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ベロ細胞」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

ヒト用狂犬病ワクチン接種のグローバル主要企業は、Bharat Biotech、 Bavarian Nordic、 Sanofi-Pasteur、 Chengda Bio、 KANGH、 Prcmise、 Henan Grand Biopharma、 Zhuoyi Biological、 ZhongKe Biopharm、 Ningbo Rongan Biological、 Indian Immunologicalsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、ヒト用狂犬病ワクチン接種のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のヒト用狂犬病ワクチン接種市場：タイプ別、2018年-2023年、2024年-2029年
世界のヒト用狂犬病ワクチン接種市場：タイプ別市場シェア、2022年
・ベロ細胞、BHK、ニワトリ胚細胞、ヒト二倍体細胞、その他

世界のヒト用狂犬病ワクチン接種市場：用途別、2018年-2023年、2024年-2029年
世界のヒト用狂犬病ワクチン接種市場：用途別市場シェア、2022年
・曝露前、曝露後

世界のヒト用狂犬病ワクチン接種市場：地域・国別、2018年-2023年、2024年-2029年
世界のヒト用狂犬病ワクチン接種市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるヒト用狂犬病ワクチン接種のグローバル売上、2018年-2023年
・主要企業におけるヒト用狂犬病ワクチン接種のグローバル売上シェア、2022年
・主要企業におけるヒト用狂犬病ワクチン接種のグローバル販売量、2018年-2023年
・主要企業におけるヒト用狂犬病ワクチン接種のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Bharat Biotech、 Bavarian Nordic、 Sanofi-Pasteur、 Chengda Bio、 KANGH、 Prcmise、 Henan Grand Biopharma、 Zhuoyi Biological、 ZhongKe Biopharm、 Ningbo Rongan Biological、 Indian Immunologicals

*************************************************************

・調査・分析レポートの概要
ヒト用狂犬病ワクチン接種市場の定義
市場セグメント
世界のヒト用狂犬病ワクチン接種市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のヒト用狂犬病ワクチン接種市場規模
世界のヒト用狂犬病ワクチン接種市場規模：2022年 VS 2029年
世界のヒト用狂犬病ワクチン接種市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのヒト用狂犬病ワクチン接種の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のヒト用狂犬病ワクチン接種製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ベロ細胞、BHK、ニワトリ胚細胞、ヒト二倍体細胞、その他
ヒト用狂犬病ワクチン接種のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：曝露前、曝露後
ヒト用狂犬病ワクチン接種の用途別グローバル売上・予測

・地域別市場分析
地域別ヒト用狂犬病ワクチン接種市場規模 2022年と2029年
地域別ヒト用狂犬病ワクチン接種売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Bharat Biotech、 Bavarian Nordic、 Sanofi-Pasteur、 Chengda Bio、 KANGH、 Prcmise、 Henan Grand Biopharma、 Zhuoyi Biological、 ZhongKe Biopharm、 Ningbo Rongan Biological、 Indian Immunologicals
...

Rabies Vaccine is an immunization drug used to prevent rabies in people who have been bitten by an animal or otherwise exposed to the rabies virus.
This report aims to provide a comprehensive presentation of the global market for Human Rabies Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Rabies Vaccination. This report contains market size and forecasts of Human Rabies Vaccination in global, including the following market information:
Global Human Rabies Vaccination Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Human Rabies Vaccination Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Human Rabies Vaccination companies in 2022 (%)
The global Human Rabies Vaccination market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Vero Cell Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Human Rabies Vaccination include Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, Chengda Bio, KANGH, Prcmise, Henan Grand Biopharma, Zhuoyi Biological and ZhongKe Biopharm, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Rabies Vaccination manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Rabies Vaccination Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Human Rabies Vaccination Market Segment Percentages, by Type, 2022 (%)
Vero Cell
BHK
Chick Embryo Cell
Human Diploid Cells
Others
Global Human Rabies Vaccination Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Human Rabies Vaccination Market Segment Percentages, by Application, 2022 (%)
Pre-exposure
Post-exposure
Global Human Rabies Vaccination Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Human Rabies Vaccination Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Rabies Vaccination revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Human Rabies Vaccination revenues share in global market, 2022 (%)
Key companies Human Rabies Vaccination sales in global market, 2018-2023 (Estimated), (Units)
Key companies Human Rabies Vaccination sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bharat Biotech
Bavarian Nordic
Sanofi-Pasteur
Chengda Bio
KANGH
Prcmise
Henan Grand Biopharma
Zhuoyi Biological
ZhongKe Biopharm
Ningbo Rongan Biological
Indian Immunologicals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Human Rabies Vaccination, market overview.
Chapter 2: Global Human Rabies Vaccination market size in revenue and volume.
Chapter 3: Detailed analysis of Human Rabies Vaccination manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Rabies Vaccination in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Human Rabies Vaccination capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Human Rabies Vaccination Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Rabies Vaccination Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Rabies Vaccination Overall Market Size
2.1 Global Human Rabies Vaccination Market Size: 2022 VS 2029
2.2 Global Human Rabies Vaccination Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Human Rabies Vaccination Sales: 2018-2029
3 Company Landscape
3.1 Top Human Rabies Vaccination Players in Global Market
3.2 Top Global Human Rabies Vaccination Companies Ranked by Revenue
3.3 Global Human Rabies Vaccination Revenue by Companies
3.4 Global Human Rabies Vaccination Sales by Companies
3.5 Global Human Rabies Vaccination Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Human Rabies Vaccination Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Human Rabies Vaccination Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Rabies Vaccination Players in Global Market
3.8.1 List of Global Tier 1 Human Rabies Vaccination Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Rabies Vaccination Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Human Rabies Vaccination Market Size Markets, 2022 & 2029
4.1.2 Vero Cell
4.1.3 BHK
4.1.4 Chick Embryo Cell
4.1.5 Human Diploid Cells
4.1.6 Others
4.2 By Type – Global Human Rabies Vaccination Revenue & Forecasts
4.2.1 By Type – Global Human Rabies Vaccination Revenue, 2018-2023
4.2.2 By Type – Global Human Rabies Vaccination Revenue, 2024-2029
4.2.3 By Type – Global Human Rabies Vaccination Revenue Market Share, 2018-2029
4.3 By Type – Global Human Rabies Vaccination Sales & Forecasts
4.3.1 By Type – Global Human Rabies Vaccination Sales, 2018-2023
4.3.2 By Type – Global Human Rabies Vaccination Sales, 2024-2029
4.3.3 By Type – Global Human Rabies Vaccination Sales Market Share, 2018-2029
4.4 By Type – Global Human Rabies Vaccination Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Human Rabies Vaccination Market Size, 2022 & 2029
5.1.2 Pre-exposure
5.1.3 Post-exposure
5.2 By Application – Global Human Rabies Vaccination Revenue & Forecasts
5.2.1 By Application – Global Human Rabies Vaccination Revenue, 2018-2023
5.2.2 By Application – Global Human Rabies Vaccination Revenue, 2024-2029
5.2.3 By Application – Global Human Rabies Vaccination Revenue Market Share, 2018-2029
5.3 By Application – Global Human Rabies Vaccination Sales & Forecasts
5.3.1 By Application – Global Human Rabies Vaccination Sales, 2018-2023
5.3.2 By Application – Global Human Rabies Vaccination Sales, 2024-2029
5.3.3 By Application – Global Human Rabies Vaccination Sales Market Share, 2018-2029
5.4 By Application – Global Human Rabies Vaccination Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Human Rabies Vaccination Market Size, 2022 & 2029
6.2 By Region – Global Human Rabies Vaccination Revenue & Forecasts
6.2.1 By Region – Global Human Rabies Vaccination Revenue, 2018-2023
6.2.2 By Region – Global Human Rabies Vaccination Revenue, 2024-2029
6.2.3 By Region – Global Human Rabies Vaccination Revenue Market Share, 2018-2029
6.3 By Region – Global Human Rabies Vaccination Sales & Forecasts
6.3.1 By Region – Global Human Rabies Vaccination Sales, 2018-2023
6.3.2 By Region – Global Human Rabies Vaccination Sales, 2024-2029
6.3.3 By Region – Global Human Rabies Vaccination Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Human Rabies Vaccination Revenue, 2018-2029
6.4.2 By Country – North America Human Rabies Vaccination Sales, 2018-2029
6.4.3 US Human Rabies Vaccination Market Size, 2018-2029
6.4.4 Canada Human Rabies Vaccination Market Size, 2018-2029
6.4.5 Mexico Human Rabies Vaccination Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Human Rabies Vaccination Revenue, 2018-2029
6.5.2 By Country – Europe Human Rabies Vaccination Sales, 2018-2029
6.5.3 Germany Human Rabies Vaccination Market Size, 2018-2029
6.5.4 France Human Rabies Vaccination Market Size, 2018-2029
6.5.5 U.K. Human Rabies Vaccination Market Size, 2018-2029
6.5.6 Italy Human Rabies Vaccination Market Size, 2018-2029
6.5.7 Russia Human Rabies Vaccination Market Size, 2018-2029
6.5.8 Nordic Countries Human Rabies Vaccination Market Size, 2018-2029
6.5.9 Benelux Human Rabies Vaccination Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Human Rabies Vaccination Revenue, 2018-2029
6.6.2 By Region – Asia Human Rabies Vaccination Sales, 2018-2029
6.6.3 China Human Rabies Vaccination Market Size, 2018-2029
6.6.4 Japan Human Rabies Vaccination Market Size, 2018-2029
6.6.5 South Korea Human Rabies Vaccination Market Size, 2018-2029
6.6.6 Southeast Asia Human Rabies Vaccination Market Size, 2018-2029
6.6.7 India Human Rabies Vaccination Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Human Rabies Vaccination Revenue, 2018-2029
6.7.2 By Country – South America Human Rabies Vaccination Sales, 2018-2029
6.7.3 Brazil Human Rabies Vaccination Market Size, 2018-2029
6.7.4 Argentina Human Rabies Vaccination Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Human Rabies Vaccination Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Human Rabies Vaccination Sales, 2018-2029
6.8.3 Turkey Human Rabies Vaccination Market Size, 2018-2029
6.8.4 Israel Human Rabies Vaccination Market Size, 2018-2029
6.8.5 Saudi Arabia Human Rabies Vaccination Market Size, 2018-2029
6.8.6 UAE Human Rabies Vaccination Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Bharat Biotech
7.1.1 Bharat Biotech Company Summary
7.1.2 Bharat Biotech Business Overview
7.1.3 Bharat Biotech Human Rabies Vaccination Major Product Offerings
7.1.4 Bharat Biotech Human Rabies Vaccination Sales and Revenue in Global (2018-2023)
7.1.5 Bharat Biotech Key News & Latest Developments
7.2 Bavarian Nordic
7.2.1 Bavarian Nordic Company Summary
7.2.2 Bavarian Nordic Business Overview
7.2.3 Bavarian Nordic Human Rabies Vaccination Major Product Offerings
7.2.4 Bavarian Nordic Human Rabies Vaccination Sales and Revenue in Global (2018-2023)
7.2.5 Bavarian Nordic Key News & Latest Developments
7.3 Sanofi-Pasteur
7.3.1 Sanofi-Pasteur Company Summary
7.3.2 Sanofi-Pasteur Business Overview
7.3.3 Sanofi-Pasteur Human Rabies Vaccination Major Product Offerings
7.3.4 Sanofi-Pasteur Human Rabies Vaccination Sales and Revenue in Global (2018-2023)
7.3.5 Sanofi-Pasteur Key News & Latest Developments
7.4 Chengda Bio
7.4.1 Chengda Bio Company Summary
7.4.2 Chengda Bio Business Overview
7.4.3 Chengda Bio Human Rabies Vaccination Major Product Offerings
7.4.4 Chengda Bio Human Rabies Vaccination Sales and Revenue in Global (2018-2023)
7.4.5 Chengda Bio Key News & Latest Developments
7.5 KANGH
7.5.1 KANGH Company Summary
7.5.2 KANGH Business Overview
7.5.3 KANGH Human Rabies Vaccination Major Product Offerings
7.5.4 KANGH Human Rabies Vaccination Sales and Revenue in Global (2018-2023)
7.5.5 KANGH Key News & Latest Developments
7.6 Prcmise
7.6.1 Prcmise Company Summary
7.6.2 Prcmise Business Overview
7.6.3 Prcmise Human Rabies Vaccination Major Product Offerings
7.6.4 Prcmise Human Rabies Vaccination Sales and Revenue in Global (2018-2023)
7.6.5 Prcmise Key News & Latest Developments
7.7 Henan Grand Biopharma
7.7.1 Henan Grand Biopharma Company Summary
7.7.2 Henan Grand Biopharma Business Overview
7.7.3 Henan Grand Biopharma Human Rabies Vaccination Major Product Offerings
7.7.4 Henan Grand Biopharma Human Rabies Vaccination Sales and Revenue in Global (2018-2023)
7.7.5 Henan Grand Biopharma Key News & Latest Developments
7.8 Zhuoyi Biological
7.8.1 Zhuoyi Biological Company Summary
7.8.2 Zhuoyi Biological Business Overview
7.8.3 Zhuoyi Biological Human Rabies Vaccination Major Product Offerings
7.8.4 Zhuoyi Biological Human Rabies Vaccination Sales and Revenue in Global (2018-2023)
7.8.5 Zhuoyi Biological Key News & Latest Developments
7.9 ZhongKe Biopharm
7.9.1 ZhongKe Biopharm Company Summary
7.9.2 ZhongKe Biopharm Business Overview
7.9.3 ZhongKe Biopharm Human Rabies Vaccination Major Product Offerings
7.9.4 ZhongKe Biopharm Human Rabies Vaccination Sales and Revenue in Global (2018-2023)
7.9.5 ZhongKe Biopharm Key News & Latest Developments
7.10 Ningbo Rongan Biological
7.10.1 Ningbo Rongan Biological Company Summary
7.10.2 Ningbo Rongan Biological Business Overview
7.10.3 Ningbo Rongan Biological Human Rabies Vaccination Major Product Offerings
7.10.4 Ningbo Rongan Biological Human Rabies Vaccination Sales and Revenue in Global (2018-2023)
7.10.5 Ningbo Rongan Biological Key News & Latest Developments
7.11 Indian Immunologicals
7.11.1 Indian Immunologicals Company Summary
7.11.2 Indian Immunologicals Human Rabies Vaccination Business Overview
7.11.3 Indian Immunologicals Human Rabies Vaccination Major Product Offerings
7.11.4 Indian Immunologicals Human Rabies Vaccination Sales and Revenue in Global (2018-2023)
7.11.5 Indian Immunologicals Key News & Latest Developments
8 Global Human Rabies Vaccination Production Capacity, Analysis
8.1 Global Human Rabies Vaccination Production Capacity, 2018-2029
8.2 Human Rabies Vaccination Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Rabies Vaccination Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Human Rabies Vaccination Supply Chain Analysis
10.1 Human Rabies Vaccination Industry Value Chain
10.2 Human Rabies Vaccination Upstream Market
10.3 Human Rabies Vaccination Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Rabies Vaccination Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Human Rabies Vaccination in Global Market
Table 2. Top Human Rabies Vaccination Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Human Rabies Vaccination Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Human Rabies Vaccination Revenue Share by Companies, 2018-2023
Table 5. Global Human Rabies Vaccination Sales by Companies, (Units), 2018-2023
Table 6. Global Human Rabies Vaccination Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Human Rabies Vaccination Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Human Rabies Vaccination Product Type
Table 9. List of Global Tier 1 Human Rabies Vaccination Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Rabies Vaccination Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Human Rabies Vaccination Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Human Rabies Vaccination Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Human Rabies Vaccination Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Human Rabies Vaccination Sales (Units), 2018-2023
Table 15. By Type - Global Human Rabies Vaccination Sales (Units), 2024-2029
Table 16. By Application – Global Human Rabies Vaccination Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Human Rabies Vaccination Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Human Rabies Vaccination Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Human Rabies Vaccination Sales (Units), 2018-2023
Table 20. By Application - Global Human Rabies Vaccination Sales (Units), 2024-2029
Table 21. By Region – Global Human Rabies Vaccination Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Human Rabies Vaccination Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Human Rabies Vaccination Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Human Rabies Vaccination Sales (Units), 2018-2023
Table 25. By Region - Global Human Rabies Vaccination Sales (Units), 2024-2029
Table 26. By Country - North America Human Rabies Vaccination Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Human Rabies Vaccination Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Human Rabies Vaccination Sales, (Units), 2018-2023
Table 29. By Country - North America Human Rabies Vaccination Sales, (Units), 2024-2029
Table 30. By Country - Europe Human Rabies Vaccination Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Human Rabies Vaccination Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Human Rabies Vaccination Sales, (Units), 2018-2023
Table 33. By Country - Europe Human Rabies Vaccination Sales, (Units), 2024-2029
Table 34. By Region - Asia Human Rabies Vaccination Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Human Rabies Vaccination Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Human Rabies Vaccination Sales, (Units), 2018-2023
Table 37. By Region - Asia Human Rabies Vaccination Sales, (Units), 2024-2029
Table 38. By Country - South America Human Rabies Vaccination Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Human Rabies Vaccination Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Human Rabies Vaccination Sales, (Units), 2018-2023
Table 41. By Country - South America Human Rabies Vaccination Sales, (Units), 2024-2029
Table 42. By Country - Middle East & Africa Human Rabies Vaccination Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Human Rabies Vaccination Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Human Rabies Vaccination Sales, (Units), 2018-2023
Table 45. By Country - Middle East & Africa Human Rabies Vaccination Sales, (Units), 2024-2029
Table 46. Bharat Biotech Company Summary
Table 47. Bharat Biotech Human Rabies Vaccination Product Offerings
Table 48. Bharat Biotech Human Rabies Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Bharat Biotech Key News & Latest Developments
Table 50. Bavarian Nordic Company Summary
Table 51. Bavarian Nordic Human Rabies Vaccination Product Offerings
Table 52. Bavarian Nordic Human Rabies Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Bavarian Nordic Key News & Latest Developments
Table 54. Sanofi-Pasteur Company Summary
Table 55. Sanofi-Pasteur Human Rabies Vaccination Product Offerings
Table 56. Sanofi-Pasteur Human Rabies Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Sanofi-Pasteur Key News & Latest Developments
Table 58. Chengda Bio Company Summary
Table 59. Chengda Bio Human Rabies Vaccination Product Offerings
Table 60. Chengda Bio Human Rabies Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Chengda Bio Key News & Latest Developments
Table 62. KANGH Company Summary
Table 63. KANGH Human Rabies Vaccination Product Offerings
Table 64. KANGH Human Rabies Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. KANGH Key News & Latest Developments
Table 66. Prcmise Company Summary
Table 67. Prcmise Human Rabies Vaccination Product Offerings
Table 68. Prcmise Human Rabies Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Prcmise Key News & Latest Developments
Table 70. Henan Grand Biopharma Company Summary
Table 71. Henan Grand Biopharma Human Rabies Vaccination Product Offerings
Table 72. Henan Grand Biopharma Human Rabies Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Henan Grand Biopharma Key News & Latest Developments
Table 74. Zhuoyi Biological Company Summary
Table 75. Zhuoyi Biological Human Rabies Vaccination Product Offerings
Table 76. Zhuoyi Biological Human Rabies Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Zhuoyi Biological Key News & Latest Developments
Table 78. ZhongKe Biopharm Company Summary
Table 79. ZhongKe Biopharm Human Rabies Vaccination Product Offerings
Table 80. ZhongKe Biopharm Human Rabies Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. ZhongKe Biopharm Key News & Latest Developments
Table 82. Ningbo Rongan Biological Company Summary
Table 83. Ningbo Rongan Biological Human Rabies Vaccination Product Offerings
Table 84. Ningbo Rongan Biological Human Rabies Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Ningbo Rongan Biological Key News & Latest Developments
Table 86. Indian Immunologicals Company Summary
Table 87. Indian Immunologicals Human Rabies Vaccination Product Offerings
Table 88. Indian Immunologicals Human Rabies Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Indian Immunologicals Key News & Latest Developments
Table 90. Human Rabies Vaccination Production Capacity (Units) of Key Manufacturers in Global Market, 2021-2023 (Units)
Table 91. Global Human Rabies Vaccination Capacity Market Share of Key Manufacturers, 2021-2023
Table 92. Global Human Rabies Vaccination Production by Region, 2018-2023 (Units)
Table 93. Global Human Rabies Vaccination Production by Region, 2024-2029 (Units)
Table 94. Human Rabies Vaccination Market Opportunities & Trends in Global Market
Table 95. Human Rabies Vaccination Market Drivers in Global Market
Table 96. Human Rabies Vaccination Market Restraints in Global Market
Table 97. Human Rabies Vaccination Raw Materials
Table 98. Human Rabies Vaccination Raw Materials Suppliers in Global Market
Table 99. Typical Human Rabies Vaccination Downstream
Table 100. Human Rabies Vaccination Downstream Clients in Global Market
Table 101. Human Rabies Vaccination Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Human Rabies Vaccination Segment by Type in 2022
Figure 2. Human Rabies Vaccination Segment by Application in 2022
Figure 3. Global Human Rabies Vaccination Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Human Rabies Vaccination Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Human Rabies Vaccination Revenue, 2018-2029 (US$, Mn)
Figure 7. Human Rabies Vaccination Sales in Global Market: 2018-2029 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Human Rabies Vaccination Revenue in 2022
Figure 9. By Type - Global Human Rabies Vaccination Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Human Rabies Vaccination Revenue Market Share, 2018-2029
Figure 11. By Type - Global Human Rabies Vaccination Sales Market Share, 2018-2029
Figure 12. By Type - Global Human Rabies Vaccination Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Human Rabies Vaccination Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Human Rabies Vaccination Revenue Market Share, 2018-2029
Figure 15. By Application - Global Human Rabies Vaccination Sales Market Share, 2018-2029
Figure 16. By Application - Global Human Rabies Vaccination Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Human Rabies Vaccination Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Human Rabies Vaccination Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Human Rabies Vaccination Revenue Market Share, 2018-2029
Figure 20. By Region - Global Human Rabies Vaccination Sales Market Share, 2018-2029
Figure 21. By Country - North America Human Rabies Vaccination Revenue Market Share, 2018-2029
Figure 22. By Country - North America Human Rabies Vaccination Sales Market Share, 2018-2029
Figure 23. US Human Rabies Vaccination Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Human Rabies Vaccination Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Human Rabies Vaccination Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Human Rabies Vaccination Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Human Rabies Vaccination Sales Market Share, 2018-2029
Figure 28. Germany Human Rabies Vaccination Revenue, (US$, Mn), 2018-2029
Figure 29. France Human Rabies Vaccination Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Human Rabies Vaccination Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Human Rabies Vaccination Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Human Rabies Vaccination Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Human Rabies Vaccination Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Human Rabies Vaccination Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Human Rabies Vaccination Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Human Rabies Vaccination Sales Market Share, 2018-2029
Figure 37. China Human Rabies Vaccination Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Human Rabies Vaccination Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Human Rabies Vaccination Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Human Rabies Vaccination Revenue, (US$, Mn), 2018-2029
Figure 41. India Human Rabies Vaccination Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Human Rabies Vaccination Revenue Market Share, 2018-2029
Figure 43. By Country - South America Human Rabies Vaccination Sales Market Share, 2018-2029
Figure 44. Brazil Human Rabies Vaccination Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Human Rabies Vaccination Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Human Rabies Vaccination Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Human Rabies Vaccination Sales Market Share, 2018-2029
Figure 48. Turkey Human Rabies Vaccination Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Human Rabies Vaccination Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Human Rabies Vaccination Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Human Rabies Vaccination Revenue, (US$, Mn), 2018-2029
Figure 52. Global Human Rabies Vaccination Production Capacity (Units), 2018-2029
Figure 53. The Percentage of Production Human Rabies Vaccination by Region, 2022 VS 2029
Figure 54. Human Rabies Vaccination Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ヒト用狂犬病ワクチン接種の世界市場見通し2023年-2029年(Human Rabies Vaccination Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

ヒト用狂犬病ワクチン接種の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp